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Key points
 Acclimatization to hypoxia leads to a reduction in plasma volume (PV) that restores arterial O2
content.
 Findings from studies investigating the mechanisms underlying this PV contraction have been
controversial, possibly as experimental conditions were inadequately controlled.
 We examined the mechanisms underlying the PV contraction evoked by 4 days of exposure to
hypobaric hypoxia (HH) in 11 healthy lowlanders, while strictly controlling water intake, diet,
temperature and physical activity.
 Exposure to HH-induced an ∼10% PV contraction that was accompanied by a reduction in total
circulating protein mass, whereas diuretic fluid loss and total body water remained unchanged.
 Our data support an oncotically driven fluid redistribution from the intra- to the extravascular
space, rather than fluid loss, as the mechanism underlying HH-induced PV contraction.
Abstract Extended hypoxic exposure reduces plasma volume (PV). The mechanisms underlying
this effect are controversial, possibly as previous studies have been confounded by inconsistent
experimental conditions. Here, we investigated the effect of hypobaric hypoxia (HH) on PV in a
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cross-over study that strictly controlled for diet, water intake, physical activity and temperature.
Elevenmales completed two 4-day sojourns in a hypobaric chamber, one in normoxia (NX) and one
in HH equivalent to 3500 m altitude. PV, urine output, volume-regulating hormones and plasma
protein concentration were determined daily. Total body water (TBW) was determined at the end of
both sojourns by deuterium dilution. Although PV was 8.1 ± 5.8% lower in HH than in NX after
24 h and remained ∼10% lower thereafter (all P < 0.002), no differences were detected in TBW
(P = 0.17) or in 24 h urine volumes (all P > 0.23). Plasma renin activity and circulating aldosterone
were suppressed in HH during the first half of the sojourn (all P < 0.05) but thereafter similar to
NX, whereas no differences were detected for copeptin between sojourns (all P > 0.05). Markers
for atrial natriuretic peptide were higher in HH than NX after 30 min (P = 0.001) but lower during
the last 2 days (P < 0.001). While plasma protein concentration was similar between sojourns, total
circulating protein mass (TCP) was reduced in HH at the same time points as PV (all P < 0.03).
Despite transient hormonal changes favouring increased diuresis, HH did not enhance urine output.
Instead, the maintained TBW and reduced TCP support an oncotically driven fluid redistribution
into the extravascular compartment as the mechanism underlying PV contraction.
(Received 10 August 2020; accepted after revision 27 October 2020; first published online 30 October 2020)
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Introduction
During acute hypoxic exposure, an increase in cardiac
output is required for the preservation of systemic O2
delivery in the face of reduced arterial oxygen content
(CaO2) (Vogel & Harris, 1967). However, as exposure
extends, CaO2 is restored by a progressive reduction
in plasma volume (PV) and the resulting increase in
arterial haemoglobin concentration ([Hb]) (Bärtsch &
Saltin, 2008).Despite decades of research, themechanisms
underlying this PV contraction remain controversial.
The most widespread explanation is that PV decreases
as a consequence of a reduction in total bodywater (TBW)
caused by an increased diuresis commonly referred to as
‘altitude diuresis’ (Honig, 1989). While some studies have
indeed observed a loss of TBW(Jain et al. 1980; Singh et al.
1986; Westerterp et al. 2000) or increased urine flow in
extended hypobaric hypoxia (HH) (Zaccaria et al. 1998;
Haditsch et al. 2015), others detected no effect on TBW
(Sawka et al. 1996) or on diuresis (Bärtsch et al. 1988;
Robach et al. 2002). Altitude diuresis has been attributed
to suppression of the renin–angiotensin–aldosterone axis
and vasopressin (Zaccaria et al. 1998; Loeppky et al. 2005)
and/or an increase in atrial natriuretic peptide (ANP) (du
Souich et al. 1987). Nevertheless, also the studies that
investigated the effect of extended HH on these hormones
have reported conflicting results, as recently reviewed
(Siebenmann et al. 2017b).
An alternative explanation is that hypoxia-induced PV
contraction does not reflect a loss of TBW, but a fluid shift
from the intra- to the extravascular compartment driven
by a decrease in total circulating protein mass (TCP)
(Sawka et al. 1996). This is supported by studies reporting
a HH-induced PV contraction in the face of unchanged
TBW (Westerterp et al. 1996) and/or a decrease in TCP
(Westergaard et al. 1970; Young et al. 2019), although the
latter is not a universal finding either (Siebenmann et al.
2015).
The conflicting results of past research may not only
reflect the complexity and individual variability in the PV
response to hypoxia, but also the difficulty of maintaining
well-controlled conditions during extendedHH exposure.
Studies were usually conducted at high altitude, where
subjects were exposed to changes in water consumption,
diet, physical activity and temperature; all factors known
to independently affect PV (Sawka et al. 2000).
The aimof the present studywas therefore to investigate
the isolated effect of HH on PV by eliminating such
confounding factors. In a cross-over design, 11 male
lowlanders were exposed to NX and HH equivalent
to 3500 m altitude for 4 days each. Water intake,
diet, physical activity, temperature and sleep were
meticulously matched between sojourns. PV, TBW,
urine output, volume-regulating hormones and TCP were
repeatedly measured and compared between sojourns. To
avoid effects of diurnal variations, measurements were
performed at the same time of day in both sojourns.
Based on the results of our recent study (Siebenmann
et al. 2015), we hypothesised that: (1) HH-induced PV
reduction reflects a loss of TBW due to increased diuresis;
(2) the diuretic effects of HH are mediated by changes in
volume-regulating hormones; and (3) TCP is preserved
in HH.
Materials and methods
The study was approved by the ethics committee of the
Bolzano Hospital, Italy (No 70–2019) and conducted
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in agreement with the Declaration of Helsinki (except
registration in a database).
Subjects
Eleven healthy, non-smoking, male lowlanders
(25 ± 4 years, 181 ± 8 cm, 72 ± 12 kg, body mass
index: 22 ± 3 kg m−2) gave written informed consent
to participate in the study. All subjects lived close to sea
level and none of them had a high altitude ancestry or a
history of acute mountain sickness (AMS) or other high
altitude-related illnesses. Subjects were of low tomoderate
physical activity and did not engage in regular endurance
exercise. To avoid interference from previous hypo-
xic exposure, subjects refrained from visiting altitudes
>2000 m in the month preceding and throughout the
study.
Protocol
After a medical examination, subjects completed two
4-day sojourns in a 12m× 6m× 5m (L×W×H) hypo-
baric chamber (terraXcube, EURAC Research, Bolzano,
Italy, 262 m). One sojourn took place in NX under
unmodified barometric pressure (741 ± 4 mmHg).
During the other sojourn (HH), barometric pressure was
reduced to 493 ± 0 mmHg, simulating an altitude of
3500 m. Six subjects started with the NX and five with
the HH sojourn. The sojourns were separated by a 4-week
washout period.
Subjects reported to the laboratory on the evening
before the sojourns and spent the night in our facilities.
Both sojourns started at 06:00 the next morning, when,
for the HH sojourn, the chamber was decompressed at
a rate of 0.16 mmHg s−1 (corresponding to an ascent
of 2 m s−1). After 4 days and nights in the chamber,
both sojourns ended with final measurements on the
morning of the fifth day. Throughout the sojourns, the
mean temperatures were 22.7 ± 0.7°C and 22.0 ± 0.1°C
and the relative humidity 26 ± 4% and 21 ± 2% in NX
and HH, respectively.
Four days prior to and throughout both sojourns, the
subjects followed the same standardised diet consisting of
three main meals, three snacks and 3 l of water that was
consumed in six 0.5 l portions at predefined times. The
daily caloric intake was 2380 kcal (51% carbohydrate, 13%
protein, 36% fat) and Na+ and K+ intakes were 110 and
97mmol day−1, respectively. Alcohol was not allowed, and
coffee consumption was limited to one cup per day.
Habitual physical activity was evaluated with a
step-counter over 4 days prior to the first sojourn. Based
on this, individual daily step goals were defined, which
the subjects were instructed to reproduce by walking on
a treadmill while in the chamber. Subjects were free to
split up their steps throughout the day as they wished.
No other physical exercise was performed during the
sojourns. During the daytime, subjects could move freely
within the chamber or walk on the treadmill, whereas
from 23:00 to 07:00 they were confined to bed and lights
turned off.
Measurements
Venous blood samples were collected on the evening
preceding the sojourns (E0) and then every morning
(M1–M5) and on the first evening (E1) of the sojourns.
Morning blood samples were collected at 07:00 while
the subjects remained in bed, and evening samples
were collected at 19:00 after 30 min of supine rest.
Note that the M1 sample in the HH sojourn was
collected 30 min after reaching the target pressure of
493 mmHg. During each sojourn, total blood withdrawal
did not exceed 100 ml. At the same time points as
blood samples were collected, peripheral oxyhaemoglobin
saturation (SpO2) was estimated by pulse oxymetry
(Nonin 150 WristOx2, US) and CaO2 was approximated
as (1.34 × SpO2 × [Hb])/100, i.e. neglecting the
small amount of O2 dissolved in plasma (Pittman,
2011). Total haemoglobin mass (Hbmass) was measured
on E0 as well as on the last evening (E4) of both
sojourns by carbon monoxide (CO) rebreathing for
determination of intravascular volumes (see below).
Body weight was measured every morning (M1–M5) of
the sojourns after the first voiding. The incidence of
AMS was evaluated with the Lake Louise AMS Scoring
system (LLS) on M2–M5. The LLS is a self-reported
questionnaire consisting of five questions on typical
AMS symptoms including headache, gastrointestinal
symptoms, fatigue/weakness, dizziness/light-headedness
and sleep (Roach et al. 1993). Urine was collected
continuously throughout both sojourns and TBW was
measured over the last night by deuterium dilution. A
schematic overview over the measurement time points is
provided in Fig. 1.
Blood analyses
Blood for haematocrit (Hct) and [Hb] analyses was
collected into heparinised syringes. [Hb] and Hct were
determined by blood gas analysis (ABL90 FLEX, Radio-
meter, Copenhagen, Denmark) and by the micro method
(4 min at 13680 g), respectively.
Blood for plasma analyses was collected into
anticoagulant-covered vacutainers, separated by
centrifugation (10 min at 1600 g and 4°C) and stored
at −80°C for quantification of circulating hormones or
at 4°C for protein and electrolyte analyses. Electrolyte
concentrations ([K+], [Na+] and [Cl−]) were determined
© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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by an ion-selective electrode (cobas, Roche Diagnostics).
Creatinine ([Cr]) and plasma protein concentration
(PPC) were measured by colorimetric assays (CREJ2,
Roche Diagnostics and TP2 cobas, Roche Diagnostics,
respectively). TCP was calculated as PPC × PV.
Plasma renin activity and aldosterone concentration
were measured at steady state by radioimmunoassay
as specified previously (Nussberger et al. 1984, 1987).
Plasma concentrations of mid-regional proANP
(MR-proANP), a stable marker for ANP, and of the
vasopressin surrogate marker copeptin were performed
on a Kryptor Plus automated platform (Thermo-Fisher);
the analytical validation of this method has been
reported previously (Alehagen et al. 2011; Hunter et al.
2011). All plasma analyses were performed by blinded
investigators.
Haemoglobin mass and intravascular volumes
Hbmass was measured by CO rebreathing as recently
described (Siebenmann et al. 2017a). Briefly, after 20 min
of supine rest (including venous cannulation), subjects
were connected to a mouthpiece, through which they
breathed pure O2 from a Douglas bag for 4 min.
Thereafter, they were switched via a sliding valve to an
O2-filled circuit consisting of a 6 l rebreathing bag and a
CO2 scrubber. After collection of 2 ml of blood, a dose of
∼1.5 ml of CO per kg body weight was injected into the
rebreathing circuit. A second blood sample was collected
after 10 min of rebreathing and the volume of unabsorbed
CO in the circuit was determined (Siebenmann et al.
2017a). Blood samples were analysed in quadruplicate for
the carboxyhaemoglobin fraction (%HbCO) by a blood
gas analyser (ABL90 FLEX) and Hbmass was determined
from the volume of absorbed CO and the resulting
change in %HbCO. Red blood cell volume (RBCV), PV
and blood volume (BV) were derived for E0, M1–M5
and E1 by integration of Hbmass and the Hct and [Hb]
values determined at the respective time points with the
following equations: (1) RBCV = Hbmass × Hct/[Hb]; (2)
BV=RBCV/Hct; (3) PV=BV -RBCV (Siebenmann et al.
2017a). Note that all intravascular volumes are entered in
litres, Hct as an absolute fraction and Hbmass and [Hb] in
grams and grams/litre, respectively.
We used Hbmass from the first CO rebreathing to derive
intravascular volumes on E0, M1 and E1 and Hbmass from
the second rebreathing for intravascular volumes on M4
and M5. For M2 and M3, the average Hbmass of the two
CO rebreathings was used.
Total body water
A stock solution containing 111.24 g of deuterium oxide
(D2O, 99.88%, Cambridge Isotope Laboratories, Inc., MA,
USA) and 1900 g of mineral water was prepared. In the
evening, after voiding and before going to bed, a base-
line saliva sample was collected. Subsequently, ∼80 g
of the stock solution was ingested (the exact weight
was recorded for each subject). The cups were then
rinsed with 100 ml of tap water, which was also ingested
by the subjects to ensure that all deuterium had been
consumed. A second saliva sample was collected the next
morning (10 h later). Subjects refrained from eating or
drinking between saliva samples. To avoid an increase
in daily water intake, subjects drank 200 ml less on day
4. Isotope enrichment relative to standard mean ocean
water was determined in quadruplicate by isotope-ratio
mass spectrometry (Gasbench II – Conflo IV – Delta V
advantage, Thermo scientific, Bremen, Germany). TBW
was calculated as the deuterium dilution space divided
by 1.04 to correct for non-aqueous exchange using the
formula provided by Schoeller et al. (1980).
Figure 1. Schematic illustration of
measurements performed during the
normoxia (NX) and hypobaric hypoxia (HH)
sojourn
E0, evening before entering the hypobaric
chamber; M1–M5, first to fifth morning of the
sojourns; E1 and E4, first and fourth evening of the
sojourns; blood, collection of a venous blood
sample; SpO2, estimation of peripheral
oxyhaemoglobin saturation by pulse oxymetry;
Hbmass, determination of haemoglobin mass by
carbon monoxide rebreathing; BW, body weight
measurement; LLS, assessment of acute mountain
sickness symptoms with the Lake Louise scoring
system; TBW, assessment of total body water by
deuterium dilution.
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Table 1. Results collected on the evening before entering the chamber (E0) for both sojourns
NX HH P value
E0 E0 Paired t test
PV (ml) 3249 ± 609 3335 ± 543 0.067
Hbmass (g) 815.2 ± 130.7 811.0 ± 129.1 0.429
BV (ml) 5681 ± 967 5770 ± 917 0.102
SpO2 (%) 98.0 ± 0.6 97.8 ± 0.8 0.441
CaO2 (ml dl−1) 18.9 ± 0.8 18.4 ± 0.7 0.008∗∗
[Hb] (g dl−1) 14.4 ± 0.6 14.1 ± 0.5 0.005∗
Hct (%) 43.0 ± 1.8 42.2 ± 0.8 0.083
PPC (g dl−1) 7.2 ± 0.2 7.1 ± 0.3 0.039∗
TCP (g) 235.0 ± 45.4 235.8 ± 42.57 0.818
Renin activity (ng ml−1 h−1) 0.40 ± 0.25 0.38 ± 0.27 0.922
Aldosterone (pg ml−1) 83.5 ± 49.55 81.7 ± 39.26 0.891
Copeptin (pmol l−1) 3.67 ± 0.96 4.58 ± 2.00 0.044∗
MR-proANP (pmol l−1) 49.0 ± 24.5 46.7 ± 29.1 0.567
Plasma [Na+] (mmol l−1) 139 ± 1 139 ± 2 0.378
Plasma [Cl−] (mmol l−1) 101 ± 2 101 ± 1 0.714
Plasma [K+] (mmol l−1) 3.8 ± 0.2 3.9 ± 1.5 0.671
Abbreviations: PV, plasma volume; Hbmass, haemoglobin mass; BV, blood volume; SpO2, peripheral oxyhaemoglobin saturation; CaO2,
arterial oxygen content; [Hb], venous haemoglobin concentration; Hct, haematocrit; MR-proANP, mid-regional pro-atrial natriuretic
peptide; PPC, plasma protein concentration; TCP, total circulating protein; NX, normoxia; HH, hypobaric hypoxia; E0, evening before
entering the chamber. N = 11. Values are presented as means ± SD; ∗P < 0.05; ∗∗P < 0.01 HH vs. NX in paired t test.
Urine analyses
Every 24 h, urine volumes were determined and a 6 ml
sample of the 24 h urine was stored at 4°C for analyses
of protein concentration, [Cr], [K+] [Na+] and [Cl−]
by blinded investigators using the same methods as for
plasma analyses.
Renal filtration, reabsorption and excretion
Glomerular filtration rate (GFR) was calculated for each
day based on Cr clearance as GFR = (([Cr]urine × urine
flow rate) / [Cr]plasma), where [Cr]plasma is the average of
the Cr concentration in plasma samples collected at the
beginning and end of the 24 h urine collection and urine
flow rate is the urine output (in ml) per minute derived
from the 24 h urine volume. Daily excretion of Na+,
Cl− and K+ was calculated by multiplying the respective
urine concentration with the 24 h urine volume. Tubular
reabsorption of solutes was calculated as (GFR × average
plasma solute concentration) - solute excretion, and H2O
reabsorption was calculated as GFR - urine flow.
Statistical analyses
Paired t tests were used to assess potential pre-exposure
differences between NX and HH on E0 (Table 1) and
to compare the daily number of steps walked, Hbmass
and TBW between the two sojourns. The remaining data
were analysed bymixedmodel for repeatedmeasurements
(MMRM) with fixed factors of altitude (NX vs. HH),
order-of-sojourns (NX–HH, N = 6 or HH–NX, N = 5)
and time-point-in-chamber, and with random effect of
subject. To isolate the effect of HH from any other effects
of the chamber confinement, controlled diet, etc., pairwise
comparisons, i.e. comparing the same time point during
the NX sojourn with the corresponding one in HH, were
performed as contrasts within the MMRM model and
adjusted for multiplicity by Sidak’s method. The study
was not designed for examining changes over time. To
preserve statistical power, changes over time within one
chamber sojourn were not evaluated. Furthermore, as E0
measurements were exclusively performed to ensure that
the pre-exposure status of the subjects was comparable
despite the 4-week washout between the sojourns, these
values were not included in the MMRM analyses or in the
figures.
A small number of measurements were missing;
however, rather than imputing missing data, MMRM
analysis better controls type I error and minimises bias.
Data are presented as means ± SD and a P value <0.05
was considered statistically significant. The analysis was
performed using SAS 9.4 (SAS Institute Inc., Cary, USA).
Results
Values measured on E0 are presented in Table 1. While
most variables were similar before the two sojourns,
© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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copeptin concentration was higher and [Hb], CaO2 and
PPC were slightly, but significantly, lower before the
HH sojourn. One subject presented with very high
plasma renin activity (3.1 ng ml−1 h−1) and aldosterone
(499 pg ml−1) and copeptin (381 pmol l−1) concentration
on E0 before NX, which may have reflected a stress
response (Gideon et al. 2020) since the subject was
scared of the initial blood sampling. These values were
considered outliers and excluded from analysis.
All subjects completed the NX and HH sojourn and
none developed symptoms of AMS (LLS <3 at all times).
The prescribed diet and water intake were closely adhered
to and daily steps were almost identical between NX
and HH (6812 ± 51 vs. 6840 ± 93 steps; P = 0.622).
Due to difficulties with blood sampling, all measurements
involving blood analyses aremissing onM1 inHH for one
subject. On day 2 inNX, one subject forgot to collect urine
so that his urine volume, GFR, and electrolyte excretion
and reabsorption could not be determined. Throughout
both sojourns, six body weight measurements were
missing in NX and two in HH.
On M1, SpO2 was reduced to 84.8 ± 2.6% in HH
(vs. 98.1 ± 0.3% in NX, P < 0.001) and although
it progressively increased to 90.0 ± 2.6% until M5, it
remained significantly lower than in NX (P< 0.001 for all
time points). CaO2 was reduced to 17.0 ± 1.1 ml dl−1 in
HH on M1 (vs. 19.4 ± 0.9 ml dl−1 in NX, P < 0.001) and
remained lower than in NX until M3 (P < 0.001 for E1
and M2, P = 0.028 for M3). On M4 and M5 in HH, CaO2
in was similar to NX (18.8 ± 0.7 vs. 19.4 ± 0.7 ml dl−1,
P= 0.329 and 18.5± 0.9 vs. 19.2± 0.7 ml dl−1, P= 0.133,
respectively) due to the increases in SpO2 and [Hb] (see
below).
Effects of hypobaric hypoxia on intravascular
volumes
No differences were detected for Hbmass between NX
and HH on E0 (Table 1) or E4 (800.6 ± 129.2 g vs.
809.2 ± 127.3 g, P = 0.130). PV was similar between
NX and HH on M1 (P = 0.746) and E1 (P = 0.059)
(Fig. 2A). On M2, PV was 251 ± 196 ml lower in HH
than in NX (P = 0.001) and remained 250–350 ml lower
for the rest of the sojourn (P < 0.001 for M3 and M4;
P= 0.002 forM5). BVwas similar between sojourns on E0
(Table 1) and M1 (NX: 5539 ± 988, HH: 5310 ± 921 ml,
P = 0.395) but lower during the HH sojourn at the same
time points as PV (all P < 0.008). While [Hb] was similar
between sojourns on M1 and E1 (P = 0.678 and 0.140,
respectively), it was higher in HH than in NX from M2
to M5 (all P < 0.001) (Fig. 2B). Hct was not different
in HH on M1 (P = 0.999) but thereafter higher than in
NX for all time points (E1: P = 0.028; rest: P ≤ 0.002)
(Fig. 2C).
Figure 2. Effects of hypoxia on plasma volume
Changes in plasma volume (PV) (A), venous haemoglobin
concentration [Hb] (B) and haematocrit (Hct) (C) during a 4 day
sojourn in normoxia (NX) and hypobaric hypoxia (HH). M1–M5, first
to fifth morning of the sojourns; E1, first evening of the sojourns.
Big symbols represent means, small symbols represent individual
data;N = 11;∗P < 0.05;∗∗P < 0.01;∗∗∗P < 0.001 for time-point
comparisons between HH and NX by mixed model for repeated
measurement (MMRM) analyses. Note that the grey shaded areas
mark measurements performed in the evening whereas all other
measurements were taken in the morning.
© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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Mechanisms of plasma volume contraction
No difference was detected between NX andHH for TBW
(41.3 ± 6.1 l vs. 41.0 ± 5.9 l, P = 0.171) (Fig. 3A)
or for body weight (P > 0.964 for all days) (Fig. 3B).
Furthermore, 24 h urine volume was at no point different
between NX and HH (P > 0.230 for all days) (Fig. 3C).
While PPC was similar in NX and HH (all P > 0.070)
(Fig. 3D) TCP was 11.5 ± 10.1 g lower in HH on M2
(P = 0.029) and remained reduced until the end of the
sojourn with a maximal difference of 18.3± 13.4 g onM3
(M2–M5: P < 0.002; M1–E1: P > 0.737) (Fig. 3E). Urine
protein concentration was low throughout both sojourns,
remaining below the detection limit (4 mg dl−1) in almost
half of the measurements.
Volume-regulating hormones
Plasma renin activity was lower in HH than NX on
M1 and M2 (both P < 0.001) but similar at all other
time points (all P > 0.326) (Fig. 4A). Plasma aldosterone
concentration was lower in HH on M1 (P = 0.049), M2
(P < 0.001) and M3 (P = 0.021) but not on E1, M4
and M5 (all P ≥ 0.675) (Fig. 4B). No differences were
observed for plasma copeptin concentrations between the
two sojourns (P = 0.110 for M1 and P > 0.970 for all
other time points) (Fig. 4C). MR-proANP concentration
was higher in HH than in NX on M1 (P = 0.001) and
lower onM4 (P< 0.001) andM5 (P< 0.001), whereas no
significant differences were observed on E1, M2 and M3
(all P > 0.173) (Fig. 4D). Note that on E1 all hormones
were similar between sojourns (all P > 0.815).
Figure 3. Mechanisms of plasma volume contraction
A, individual values for total body water (TBW) assessed overnight between the fourth evening and the fifth
morning in normoxia (NX) and hypobaric hypoxia (HH). Dotted lines represent the group means. Means were
compared with pairedttest.B, changes in body weight.C, daily urine output during the sojourns.D, plasma protein
concentration (PPC).E, total circulating plasma protein (TCP) throughout the 4 day sojourns. M1–M5, first to fifth
morning of the sojourns; E1, first evening of the sojourns (grey shade). Big symbols represent means, small symbols
represent individual data;N = 11;∗P < 0.05;∗∗P < 0.01;∗∗∗P < 0.001 for time-point comparisons between HH and
NX by mixed model for repeated measurement (MMRM) analyses.
© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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Renal water and electrolyte handling
GFR (Fig. 5A) and tubular H2O reabsorption (Fig. 5B)
were lower in HH than in NX on day 3 (P = 0.008 and
P= 0.009, respectively), whereas no significant differences
were detected on days 1–2 (all P > 0.503) or on day 4
(P= 0.056 and P= 0.059, respectively). Na+ reabsorption
(Fig. 5C) was lower in HH on days 3 and 4 (P = 0.006
and P = 0.043, respectively; all other P > 0.486), whereas
Na+ excretion (Fig. 5D) did not differ between the two
sojourns (all P > 0.440). Reabsorption of Cl− was lower
in HH on day 3 (P = 0.035; all other P > 0.176) (Fig. 5E)
while Cl− excretion was similar to NX (all P > 0.163;
Fig. 5F). No difference was observed for K+ reabsorption
between NX and HH (all P > 0.317) (Fig. 5G) but K+
excretion was lower in HH on day 2 (P = 0.002; day
1: P = 0.066; days 3–4: P > 0.133) (Fig. 5H). Plasma
electrolyte concentrations are provided in Table 2. Plasma
[Na+] was similar between NX and HH at all time points,
whereas [Cl−] was higher in HH on M2, M3 and M5 and
[K+] was higher in HH on M3 (Table 2).
Discussion
We investigated the mechanisms underlying
hypoxia-induced PV contraction in a hypobaric chamber,
while meticulously controlling for factors that typically
confound field studies at high altitude. Four days of HH
equivalent to 3500 m altitude reduced PV by ∼10%.
Figure 4. Volume-regulating hormones
Changes in renin (A), aldosterone (B), copeptin (C) and mid-regional pro-atrial natriuretic peptide (MR-proANP)
(D) concentrations during the normoxia (NX) and hypobaric hypoxia (HH) sojourn. For graphing purposes, values
that exceeded the normal range by more than 200% were excluded from the mean and SD in (C). The values are
plotted individually as black (NX) and white (HH) squares. Big symbols represent means, small symbols represent
individual data;N = 11;∗P < 0.05;∗∗P < 0.01;∗∗∗P < 0.001 for time-point comparisons between HH and NX by
mixed model for repeated measurement (MMRM) analyses. Grey shaded areas mark evening measurements.
© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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Contrary to our hypotheses, and despite transient
hormonal changes favouring diuretic water loss, this PV
reduction was not associated with increased diuresis and
a consequent loss of TBW. Instead, TCP decreased during
HH, supporting an oncotically driven fluid redistribution
from the intra- to the extravascular space.
PV contraction is an almost universal finding in
healthy lowlanders exposed to HH equivalent to altitudes
>2000 m (Siebenmann et al. 2017b), although exceptions
occur in individuals developing AMS (Hackett et al. 1982;
Bärtsch et al. 1988; Loeppky et al. 2005) or when HH
exposure is combined with strenuous exercise (Levine &
Stray-Gundersen, 1997; Gore et al. 1998). In the current
study, PV decreased primarily during the first 24 h of HH,
and changed little thereafter, which aligns with a recent
model predicting the time course of PV changes at high
altitude (Beidleman et al. 2017) and also the magnitude of
PV reduction was in the same range (6–14%) as in pre-
vious studies at altitudes of ∼3500 m (Siggaard-Andersen
et al. 1968; Jung et al. 1971; Singh et al. 1986; Siebenmann
et al. 2015).
HH-induced PV contraction is often attributed to a
decrease in TBW (Jain et al. 1980; Singh et al. 1986;
Westerterp et al. 2000) due to enhanced diuretic water loss
Figure 5. Renal water and electrolyte
handling
Changes in glomerular filtration rate (GFR) (A)
and tubular H2O reabsorption (B) during days
1–4 in normoxia (NX) and hypoxia (HH).
Changes in electrolyte reabsorption (C, EandG)
and excretion (D, FandH) throughout the
sojourns. Big symbols represent means, small
symbols represent individual
data;N = 11;∗P < 0.05;∗∗P < 0.01 for
time-point comparisons between HH and NX
by mixed model for repeated measurement
(MMRM) analyses.
© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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Table 2. Plasma electrolyte concentrations during two 4 day sojourns in normoxia (NX) and hypobaric hypoxia (HH)
[Na+] (mmol l−1)
M1 E1 M2 M3 M4 M5
NX 140 ± 1 139 ± 2 140 ± 1 140 ± 1 141 ± 1 140 ± 1
HH 140 ± 1 140 ± 2 140 ± 1 140 ± 2 140 ± 2 140 ± 1
P values 1.000 0.999 1.000 0.999 0.337 0.999
[Cl−] (mmol l−1)
M1 E1 M2 M3 M4 M5
NX 102 ± 2 100 ± 2 101 ± 2 101 ± 2 102 ± 2 102 ± 1
HH 102 ± 2 101 ± 2 103 ± 2 103 ± 2 103 ± 2 104 ± 1
P values 0.999 0.766 0.018∗ 0.006∗∗ 0.192 0.001∗∗∗
[K+] (mmol l−1)
M1 E1 M2 M3 M4 M5
NX 4.1 ± 0.3 3.9 ± 0.2 4.1 ± 0.3 4.0 ± 0.2 4.0 ± 0.2 4.1 ± 0.3
HH 4.1 ± 0.2 3.8 ± 0.2 4.1 ± 0.2 4.3 ±0.3 4.1 ± 0.2 4.1 ± 0.3
P values 0.933 0.408 1.000 0.001∗∗∗ 0.724 0.946
Abbreviations: M1–M5, first to fifth morning in the chamber; E1, first evening in the chamber; NX, normoxia; HH, hypobaric hypoxia.
Values represent means ± SD; N = 11; ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001 for time-point comparisons between HH and NX by mixed
model for repeated measurement (MMRM) analyses.
(Zaccaria et al. 1998; Haditsch et al. 2015). Nevertheless,
other studies have reported PV reduction in the face
of an unchanged TBW (Westerterp et al. 1996; Sawka
et al. 1996) and diuresis (Bärtsch et al. 1988; Robach
et al. 2002) at altitude. The conflicting results of past
research possibly reflect inadequate control of water
intake, physical activity, temperature and diet. In the pre-
sent study, where these confounding factors were strictly
controlled for, TBW was not different between HH and
NX. While HH exposure is often associated with a loss
of body weight (Dünnwald et al. 2019), we have not
observed any weight changes throughout the sojourns,
which probably not only reflects the controlled diet and
the low physical activity but also supports the finding
that TBW remained stable. PV constitutes only ∼20% of
extracellular fluid volume and is in unrestricted exchange
with the extravascular compartment (Sawka et al. 2015).
Accordingly, an extracellular fluid and thus TBW loss
of ∼1.7 l would have been required for the 339 ml
PV reduction observed on M4 in HH. In line with the
unchanged TBW, we also observed no effect of HH
on 24 h urine output. In contrast, two well-controlled
studies detected a marked increase in urine flow after
90 min (Hildebrandt et al. 2000) or 6 h (Swenson et al.
1995) of normobaric hypoxia (12% O2). A potential
explanation is that normobaric hypoxia with 12% O2,
which corresponds to an altitude of ∼4300 m, triggers an
increase in diuresis that does not occur in themilder hypo-
xia used in the present study. Alternatively, acute hypoxia
might induce increases in urine flow that are followed by
compensatory reductions so that the 24 h urine volume
remains unchanged. Indeed, Loeppky et al. have observed
increased urine flow during the first 9 h in HH (in sub-
jects not affected by AMS), whereas after 12 h, urine
flow was lower than in normoxia (Loeppky et al. 2005).
Nevertheless, even if such an early, transient increase in
diuresis occurred in our study, its effect on PV must have
been minor, since on E1 (i.e. after 12 h) PV was not yet
significantly lower in HH than in NX.
In addition to diuresis, it has been suggested that
enhanced natriuresis contributes to PV reduction in hypo-
xia (Swenson et al. 1995; Zaccaria et al. 1998), which was,
however, not confirmed by the present and earlier studies
(Hildebrandt et al. 2000; Loeppky et al. 2005).
The paradigm of altitude diuresis is also based on
studies reporting suppression of the renin–angiotensin–
aldosterone axis (Hogan et al. 1973; Zaccaria et al. 1998)
and/or of vasopressin (Claybaugh et al. 1978; Loeppky
et al. 2005), although none of these are consistent findings
(Siebenmann et al. 2017b). Due to its small size and short
half-life, vasopressin is technically difficult to quantify
in plasma and we therefore measured copeptin, which
is a stable and sensitive surrogate marker for vaso-
pressin (Morgenthaler, 2010), and was unaffected by HH.
However, we observed a transient reduction in plasma
renin activity and aldosterone concentration. Of note,
© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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these reductions were only detected in the morning, but
not in the evening. Renin and aldosterone follow diurnal
variations, with lower values in the evening (Hurwitz
et al. 2004), potentially leaving little margin for further
suppression by hypoxia (Kurtz, 2012). The decreased
aldosterone probably caused a reduction in sodium
reabsorption that attenuated water reabsorption by the
connecting tubule and the collecting duct (Fig. 5B–C).
The fact that these effects did not increase diuresis and
natriuresis implies a reduced GFR and hence reduced
filtered load of sodium and water. GFR was indeed lower
in HH from day 2 to 4, although statistical significance
was only reached on day 3 (Fig. 5A). This reduction in
GFR was likely a consequence of reduced renal plasma
flowdue to theHH-induced haemoconcentration (Pichler
et al. 2008). Another hormone that has been proposed to
mediate hypoxia-induced diuresis is ANP (Honig, 1989).
However, the effect of hypoxia on ANP is controversial
as increases have been observed during acute normobaric
hypoxia (<60 min) (Kawashima et al. 1989; Vonmoos
et al. 1990), and unchanged or reduced values after HH
exposure lasting several days (Bärtsch et al. 1988; Zaccaria
et al. 1998; Siebenmann et al. 2015). Collectively, these
results suggested a biphasic response, which is confirmed
by the current results, where an increase in MR-proANP
was observed after 30 min in HH and a reduction after
3 and 4 days, respectively. While the transient increase in
ANPmay contribute to the increase in urine flowobserved
during acute normobaric hypoxia (Swenson et al. 1995;
Hildebrandt et al. 2000), it is apparently too short-lived to
exert an increase in 24 h urine output.
Apart from increased diuresis, water loss via sweat,
transcutaneous evaporation, ventilation or faeces can
reduce TBW (Sawka et al. 2015). In the present study,
temperature and physical activity were matched between
sojourns, making differences in sweat loss unlikely. As
diet was controlled, and none of the subjects had gastro-
intestinal symptoms, a systematic difference in faecal
water loss between sojourns seems improbable as well
(Westerterp et al. 1996). However, respiratory and trans-
cutaneous water loss could have been higher during HH
due to lower humidity (Sawka et al. 2015) and increased
pulmonary ventilation (Wagner et al. 1987). Nevertheless,
as TBWwas unchanged, such increases in respiratory and
transcutaneous water loss must have been small, which
is in line with investigations of fluid balance at altitude
(Westerterp et al. 2000).
A reduction in PV occurs in the face of unchanged
TBW if fluid is redistributed from the intra- to the
extravascular space and this is an alternative, albeit
less widespread, explanation for hypoxia-induced PV
contraction. Several studies have found HH to promote
a loss of TCP (Westergaard et al. 1970; Sawka et al. 1996;
Young et al. 2019) and the resulting reduction in oncotic
pressure could drive a transvascular fluid shift and thus
reduce PV. In line with this, PV reduction in HH occurred
in parallel with a decrease in TCP in the present study.
A loss of plasma protein can occur in hypoxia through
multiple processes: (i) transvascular escape (Westergaard
et al. 1970), (ii) increased degradation (Surks, 1966), or
(iii) increased excretion in urine (Hansen et al. 1994). The
latter did not, however, occur in the present study as urine
protein concentrations were mostly below the detection
limit (4 mg dl−1). Even when assuming a concentration
of 4 mg dl−1 for these values, daily protein excretion was
below 140mg throughout both sojourns and hence cannot
explain the 18 g loss of TCP during HH. In contrast to the
present results, we have previously reported unchanged
TCP during 4 weeks of exposure to 3454 m (Siebenmann
et al. 2015). A potential explanation is that in the previous
study the time points of blood samplingwere not as closely
controlled as in the current study. Figure 3E suggests that
TCP is higher in the evening than in themorning and such
diurnal variations could have prevented the detection of
the mild (∼5–8%) reduction in TCP observed in the
present study. Furthermore, the uncontrolled diet in the
previous study could have been associated with a higher
protein intake that maintained TCP by accelerating
albumin synthesis (Thalacker-Mercer & Campbell,
2008).
Apart from reducing PV, hypoxic exposure also
promotes Hbmass expansion through accelerated
erythropoiesis. However, as expected (Rasmussen et al.
2013; Siebenmann et al. 2015), 4 days in HH were
insufficient for this effect to manifest. Despite this, CaO2
was restored to NX levels at the end of the HH sojourn,
which is in line with earlier findings at 3454 m altitude
(Siebenmann et al. 2015) and highlights the functional
importance of PV contraction for blood O2 transport
capacity.
There are methodological aspects to consider: a 4-day
chamber confinement with a controlled diet, physical
activity and sleep/wake cycle represents a lifestyle change
that, in itself, could affect PV and other variables
measured. To isolate the effects of hypoxia from those of
chamber confinement, a NX sojourn was performed and
variables were compared at specific time points between
the HH and NX sojourns. To preserve statistical power,
changes occurring over time during a single sojourn,
which would reflect the combined effect of HH and
chamber confinement, were not evaluated. Similarly, the
E0 measurements, which were exclusively performed
to ensure that the pre-exposure status of the subjects
was comparable despite the 4-week washout between
the sojourns, should not be interpreted as baseline
measurements. As these measurements were performed
in the evening preceding the sojourns, any PV change
occurring from E0 to M1 would not only reflect the
effect of 30 min of HH, but also of the onset of chamber
confinement as well as circadian variations (Schmidt
© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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et al. 2000). E0 values were therefore not included in the
MMRM analyses or in the figures.
We chose a severity of HH that induces a clear PV
contraction without posing too high a risk for AMS. The
latter could not only have led to subject dropouts but also
interfered with water homeostasis due to fluid retention
(Loeppky et al. 2005) or fluid loss due to gastrointestinal
symptoms (Westerterp et al. 1996).While previous studies
performed at similar altitudes reported an AMS incidence
of∼30–40% (Honigman et al. 1995; Beidleman et al. 2013,
2018; Phillips et al. 2017), none of the subjects in the
present study developed AMS. A part of the explanation
for the discrepancy may be that a history of AMS or
other high altitude-related illnesses was an exclusion
criterion. In addition, strenuous physical exercise, which
may enhance the risk for AMS (Beidleman et al. 2013),
was avoided during the sojourns. The controlled water
intake also ensured that subjects remained well-hydrated,
which could have prevented AMS (Cumbo et al. 2002;
Castellani et al. 2010). Finally, as AMS commonly strikes
during the first night at altitude (Luks et al. 2017), the
absence of AMS might have been related to the early
ascent, which extended the acclimatization time preceding
the first night.
The exposure duration of 4 days was selected as major
changes in PV are known to take place within this period
(Siebenmann et al. 2015, 2017b; Beidleman et al. 2017).
Accordingly, it seems unlikely that a different mechanism
for PV reduction would have been recruited after a longer
exposure.
Finally, we included only males as variations in PV
(Cullinane et al. 1995), (anti-)diuretic hormones (Jensen
et al. 1989; Chidambaram et al. 2002) andPPC (Ferris et al.
1962) across the menstrual cycle would have complicated
the replication of experimental conditions between NX
andHH. Follow-up studies evaluatingwhether the current
results apply to women are hence warranted.
In conclusion, HH in the absence of confounding
variables reduces PV by promoting oncotically driven
fluid shifts from the intra- to the extravascular space.
No indications of the increased urine output commonly
referred to as ‘altitude diuresis’ were observed despite
transient suppression of renin and aldosterone, and a
short-lived increase in circulating ANP. These findings
advance our understanding of the normal PV response
to HH and facilitate future investigations on the
pathophysiology of fluid retention during AMS.
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